antibodies in humans seen in monkeys and mice," Kiat Ruxrungtham, head researcher at Chulalongkorn University’s Center of Excellence in Vaccine Research and Development, said at a briefing on Sunday in Bangkok.
If the trials are successful, Thailand could have its vaccine by the second half of 2021, he said.The Thai study will begin its human trials as early as September and will be among the first done outside high-income countries.
Globally, 160 vaccines are being studied for Covid-19, of which 21 are at the clinical evaluation stage, according to the World Health Organization.Access to life-saving vaccines is a perennial issue in poorer countries.